1. Acceptability of Group PM+ |
Participants, family, CPSWs, community, psychosocial team |
Is PM+ stigmatizing? Is it acceptable for CPSW to deliver PM+? What were parts of the program that could have been changed to make the program more acceptable for the community? |
2. Implementation logistics; PM+ sites, local leadership |
CPSWs, community, RAs and research staff, psychosocial team |
How would we enhance project implementation (in terms of venue, coordination with local leadership, etc.)? |
3. Feasibility of PM+ and burden (time, frequency, distance for providers and participants) |
Participants, family, CPSWs, community, psychosocial team |
How would make this program more sustainable? How would make this program more effective? Should the program be longer? |
4. Fidelity and supervision (areas of deviation and cause, competency, amount and form of supervision) |
CPSWs, psychosocial team |
How did the CPSWs deviate from the material in the PM+ manual? Why did they deviate from the material? Was there a need for more or less supervision? What were the challenges to supervision? |
5. Utility (perceived benefit) of PM+ |
Participants, family, CPSWs, community, psychosocial team |
How do CPSWs perceive participant experience? What problems is PM+ helpful for? What problems is PM+ not helpful for? Who is PM+ useful for? |
6. Contagion |
Participants (control group), family, CPSWs, RAs and research staff, psychosocial team |
Did anyone involved in PM+ teach friends, family, and community members PM+ techniques? Did the mechanisms of action for PM+ reach the control VDC? If so, how did those in the control group learn? |
7. Blinding/randomization; sources and timing of unbinding |
CPSWs, mhGAP, community, RAs and research staff, psychosocial team |
When did RAs and CPSWs know that different groups received different treatment? How did they know about the different groups? |
8. Recruitment and retention (participants and providers) |
Participants, family, CPSWs, community, RAs and research staff, psychosocial team |
What were challenges to recruitment? What were challenges to retention of participants in the program? What are possible solutions to recruitment and retention? |
9. Adverse events, ethics, safety |
Participants, family, CPSWs, mhGAP, RAs and research staff, psychosocial team |
Were staff equipped to handle any adverse events? What was the type and fBMW80481requency of adverse events referred? |
10. Referral and control condition |
Participants, family, CPSWs, mhGAP, community, psychosocial team |
Were mhGAP services available? Was medication available in local health posts? Was the TPO counselor used by the community? Was transportation to local referrals available to those who needed it? |
11. Assessment feasibility, acceptability, interpretation |
Participants, RAs and research staff, CPSW |
Were the assessments feasible to conduct? Did the participants understand the assessments? What were the challenges to conducting assessments? |